This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 378Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
---|---|---|---|---|---|---|---|---|---|
2085 | Estrogen , Estradiol, AFP | Protein + Steroid | Human | Downregulated in liver cancer cell. | Diagnostic | Normal vs liver cancer | p < 0.05 | Serum | 27060391 |
2086 | Estrone plus Estradiol/Testosterone ratio | Steroid | Human | Downregulated in liver cancer cell. | Diagnostic | Normal vs liver cancer | p < 0.06 | Serum | 27060391 |
2087 | AFP | Protein | Human | Downregulated in liver cancer cell. | Diagnostic | Normal vs liver cancer | p < 0.06 | Serum | 27060391 |
2089 | miR-200c | miRNA | Human | Downregulated in PSC with control | Diagnostic | Normal v/s cancer v/s PSC | p < 0.05 | Serum | 26864161 |
2090 | miR-483-5p | miRNA | Human | Upregulated in CC compared with controls and PSC. | Diagnostic | Normal vs cancer | p < 0.05 | Serum | 26864161 |
2091 | miR-194 | miRNA | Human | Upregulated in CC compared with controls. | Diagnostic | Normal vs cancer | p < 0.05 | Serum | 26864161 |
2093 | miR-122 | miRNA | Human | Upregulatd in chronic HCV v/s healthy control (with log fold change 3.17) | Diagnostic | Cancer v/s Normal | p < 0.05 | Serum | 26812693 |
2094 | miR-222 | miRNA | Human | Upregulatd in chronic HCV v/s healthy control (with log fold change 3.11) | Diagnostic | Cancer v/s Normal | p < 0.01 | Serum | 26812693 |
2095 | IRF1 | RNAs | Human | Upregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) | Diagnostic | Cancer v/s Normal | FDR <0.01 | Cells | 26811688 |
2096 | GBP1 | RNAs | Human | Upregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) | Diagnostic | Normal vs HCC | FDR <0.01 | Cells | 26811688 |
2097 | ICAM1 | RNAs | Human | Upregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) | Diagnostic | Normal vs HCC | FDR <0.01 | Cells | 26811688 |
2098 | Foxa1 | RNAs | Human | Downregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) | Diagnostic | Normal vs HCC | FDR <0.01 | Cells | 26811688 |
2099 | DHCR7 | RNAs | Human | Downregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) | Diagnostic | Normal vs HCC | FDR <0.01 | Cells | 26811688 |
2100 | HMGCS2 | RNAs | Human | Downregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) | Diagnostic | Normal vs HCC | FDR <0.01 | Cells | 26811688 |
2101 | MSMO1 | RNAs | Human | Downregulated in JFH-1-infected Huh7 cells (with log fold change more than 1) | Diagnostic | Normal vs HCC | FDR <0.01 | Cells | 26811688 |
2103 | AFP-L3 | Protein | Human | Upregulated in AFP-negative HCC patients | Diagnostic | Normal vs HCC | p < 0.01 | Tissue | 26770061 |
2104 | GP73 | Protein | Human | Upregulated in AFP-negative HCC patients | Diagnostic | Normal vs HCC | p < 0.01 | Tissue | 26770061 |
2105 | AFP-L3, GP73 (combined) | Protein | Human | Upregulated in AFP-negative HCC patients | Diagnostic | Normal vs HCC | p < 0.01 | Tissue | 26770061 |
2106 | TOPO2 | Protein | Human | Downregulated in nucleolus of HCC | Diagnostic | Normal vs HCC | NA | Tissue | 26722553 |
2107 | Combination of S100A9 and GRN | Others | Human | Downregulated in HCC patients | Diagnostic and Prognostic | Normal vs HCC | p < 0.001 | Urine | 26675302 |
2108 | ABCC3 | Protein | Rat and Human | overexpressed in hepatocellular carcinoma | Potential Diagnostic * | Normal vs HCC | p < 0.01 | Tissue | 26337276 |
2113 | Alpha-ketoglutaric | Metabolite | Human | The concentrations of α-KG in diabetic II and liver cancer urine samples were significantly lower than those from healthy people. | Diagnostic | Normal vs cancer | p < 0.05 | Urine | 25871588 |
2114 | pyruvic acid | Metabolite | Human | The concentrations of PA in diabetic II and liver cancer urine samples were significantly lower than those from healthy people. | Diagnostic | Normal vs cancer | p < 0.05 | Urine | 25871588 |
2117 | RNase A | Protein | Human | Downregulated in gastric cancer, liver cancer, pancreatic cancer, esophageal cancer, ovary cancer, cervical cancer, bladder cancer, kidney cancer and lung cancer | Diagnostic | Cancer v/s Normal | p < 0.01 | Serum | 24805924 |
2119 | KIAA1114 | Protein | Human and Mice cell lines | KIAA1114 is overexpressed in human liver cancer cell lines | Potential Diagnostic * | Normal cell line vs HCC cell line | p < 0.05 | Tissue | 24713374 |
2126 | AFP (at a cut-off of 20 ng/mL) | Protein | Human | Upregulated level in HCC | Diagnostic | HCC with cirrhosis v/s HCV-associated cirrhosis | p < 0.05 | Serum | 24095974 |
2127 | DNA hypomethylated regions of GPM6B | Epigenetic (Others) | Human | hypomethylated and Upregulated level in HCC | Diagnostic | Cancer v/s Normal | p < 0.01 | Tissue | 23950870 |
2128 | DNA hypomethylated regions of MAGEA12 | Epigenetic (Others) | Human | hypomethylated and Upregulated level in HCC | Diagnostic | Cancer v/s Normal | p < 0.01 | Tissue | 23950870 |
2129 | DNA hypomethylated regions of FCRL1 | Epigenetic (Others) | Human | hypomethylated and Upregulated level in HCC | Diagnostic | Invasive HCC v/s non-invasive HCC | p < 0.01 | Tissue | 23950870 |
2130 | VTN | Protein | Human | Downregulated in HCV-infected HCC patients | Diagnostic | Normal vs HCV-infected HCC patients, Normals vs non HCV-infected HCC | p < 0.05 | Plasma | 23944848 |
2131 | SAP | Protein | Human | Downregulated in HCV-infected HCC patients | Diagnostic | Normal vs HCV-infected HCC patients, Normals vs non HCV-infected HCC | p < 0.01 | Plasma | 23944848 |
2139 | C3 | Protein | Male Wistar rats | Upregulated at very early stage in HCC | Potential Diagnostic * | Normal vs HCC | p < 0.05 | Tissue | 23245919 |
2140 | miR-18b* | miRNA | Human | Downregulated in the HCC v/s non-tumor (with fold change 0.21) | Diagnostic | Normal v/s HCC/HCV/HBV | p < 0.001 | Tissue | 23205106 |
2141 | miR-296-5p | miRNA | Human | Downregulated in the HCC v/s non-tumor (with fold change 0.16) | Diagnostic | Normal v/s HCC/HCV/HBV | p < 0.001 | Tissue | 23205106 |
2142 | miR-557 | miRNA | Human | Downregulated in the HCC v/s non-tumor (with fold change 0.29) | Diagnostic | Normal v/s HCC/HCV/HBV | p < 0.01 | Tissue | 23205106 |
2143 | miR-581 | miRNA | Human | Downregulated in the HCC v/s non-tumor (with fold change 0.10) | Diagnostic | Normal v/s HCC/HCV/HBV | p < 0.01 | Tissue | 23205106 |
2144 | miR-625* | miRNA | Human | Downregulated in the HCC v/s non-tumor (with fold change 0.23) | Diagnostic | Normal v/s HCC/HCV/HBV | p < 0.01 | Tissue | 23205106 |
2145 | miR-1228 | miRNA | Human | Downregulated in the HCC v/s non-tumor (with fold change 0.30) | Diagnostic | Normal v/s HCC/HCV/HBV | p < 0.01 | Tissue | 23205106 |
2146 | miR-1249 | miRNA | Human | Downregulated in the HCC v/s non-tumor (with fold change 0.20) | Diagnostic | Normal v/s HCC/HCV/HBV | p < 0.001 | Tissue | 23205106 |
2147 | miR-2116* | miRNA | Human | Downregulated in the HCC v/s non-tumor (with fold change 0.048) | Diagnostic | Normal v/s HCC/HCV/HBV | p < 0.05 | Tissue | 23205106 |
2148 | miR-129* | miRNA | Human | Downregulated in the HCC v/s non-tumor | Diagnostic | Normal vs HCC, liver cancer | p < 0.05 | Tissue | 23205106 |
2149 | miR-146b-3p | miRNA | Human | Downregulated in the HCC v/s non-tumor | Diagnostic | Normal vs HCC, liver cancer | p < 0.05 | Tissue | 23205106 |
2150 | miR-448 | miRNA | Human | Downregulated in the HCC v/s non-tumor | Diagnostic | Normal vs HCC, liver cancer | p < 0.05 | Tissue | 23205106 |
2151 | DJ-1 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2152 | CAF-1 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2153 | HSP60 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2154 | DJ-1, CAF-1 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2155 | DJ-1, HSP60 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2156 | CAF-1, HSP60 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |
2157 | DJ-1, CAF-1, HSP60 | Protein | Human | Upregulated in HCC | Diagnostic | Normal vs HCC with Hepatitis C and without Hepatitis C | p < 0.05 | Urine | 23074380 |